Summary of proceedings of the 16th Annual General Meeting of the Company held on 14th September, 2026

APTUS PHARMA LIMITED Date: 14.09.2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001 SECURITY CODE: 544529 SCRIPT SYMBOL: APPL SUB: Summary of Proceedings of the 16th Annual General Meeting of the Company held on September 14, 2026 Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, a summary of the proceedings of the 16th Annual General Meeting (‘AGM’) of Aptus Pharma Limited held on Monday, September 14, 2026 at 11:00 a.m., through Video Conferencing/ Other Audio-Visual Means (‘VC/OAVM’) is enclosed herewith. The Company also facilitated the live webcast of proceedings of the 16th AGM. The summary of the proceedings is also being uploaded on the Company's website www.aptus- pharma.com. . You are requested to kindly take the above on record. Thanking you, Yours faithfully, For Aptus Pharma Limited Tejash Hathi Managing Director DIN: 03151221 Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM APTUS PHARMA LIMITED SUMMARY OF THE PROCEEDINGS OF THE 16TH ANNUAL GENERAL MEETING (“AGM” OR “MEETING”) OF APTUS PHARMA LIMITED HELD THROUGH VIDEO CONFERENCING (‘VC’)/OTHER AUDIO-VISUAL MEANS (OAVM) ON MONDAY, 14TH SEPTEMBER, 2026 Meeting Details: The AGM was held on Monday, 14th September, 2026, at 11:00 a.m. (IST) through VC/OAVM. The Meeting commenced at 11:00 a.m. (IST). The Meeting was called, convened and conducted in compliance with the applicable provisions of Companies Act, 2013 (“the Act”) and the Rules made thereunder and Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with General Circulars Nos. 14/2020 dated April 8, 2020 and subsequent circulars issued in this regard, the latest being 3/2025 dated September 22, 2025, collectively referred to as “MCA Circulars” as well as Secretarial Standard on General Meetings (SS-2). Chairman: The Chairman of the Company, Mr. Chetan Shantilal Lalseta joined the meeting and presided over the Meeting as Chairman in terms of Article 103 of the Articles of Association of the Company. Directors in attendance: Designation & Chairmanship Sr. No. Name of Director Location of Committee 1. Chetan Shantilal Lalseta Director & Chairman Rajkot Tejash Maheshchandra 2. Managing Director Rajkot Hathi Director & Chairman of the Riddhish Natwarlal 3. Stakeholders Relationship Rajkot Tanna Committee Independent Director & 4. Sejal Harit Palan Chairperson of the Audit Rajkot Committee Independent Director & Vikas Rambhai 5. Chairman of the Nomination Anand Jobanputra and Remuneration Committee Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM APTUS PHARMA LIMITED Jyotiben Hasmukhbhai 6. Director Rajkot Chandarana Other Key Managerial Persons in attendance Name of Director Designation Location 1. Ghanshyam Vinubhai Pansuriya Chief Executive Officer Rajkot 2. Kapilbhai Hasmukhbhai Chandarana Chief Financial Officer Rajkot 3. Mohini Hardikbhai Gandhi Company Secretary Rajkot The Statutory Auditors, Secretarial Auditor and the Scrutinizer were also present through VC from Rajkot. Members attending the Meeting: 28 Members had attended the Meeting. In terms of the circulars issued by MCA and SEBI, the requirement of appointing proxy was not applicable. Quorum: The requisite quorum as required under Section 103 of the Act was present throughout the Meeting. E-voting during the meeting: The Members attending the Meeting who had the right to vote but had not cast their votes through Remote e-Voting were given the opportunity to vote using the e-Voting platform of CDSL, which was activated from the beginning of the Meeting and till 15 minutes after the conclusion of the proceedings. Proceedings of the Meeting: Ms. Mohini Hardik Bhai Gandhi, Company Secretary, welcomed the Members to the Meeting and briefed them on certain points relating to the participation at the Meeting and informed the Members that a live streaming of the proceedings of the Meeting was webcast on the website of Central Depository Services (India) Limited (“CDSL”). The Company had taken requisite steps to enable Members to participate and vote on the items of businesses considered at the AGM. The remote e voting period was open from Friday, 11th September, Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM APTUS PHARMA LIMITED 2026 at 09:00 A.M. to Sunday, 13th September, 2026 at 05:00 P.M. She further informed the Shareholders that the facility for e-voting would also be available during the AGM to enable those Shareholders who had not cast their votes through remote e-voting to cast their votes electronically. The requisite quorum for the Meeting being present, the Chairman called the Meeting to order. Statutory Registers under the Act, and other relevant documents as required to be kept open in terms of the resolutions provided in the AGM Notice, were available for inspection of the Members electronically. Since the Auditor’s Report, on the Financial Statements for the year ended March 31, 2026, and Secretarial Audit Report did not have any qualifications, reservations, observations, adverse remarks or disclaimer regarding the financial transactions or matters adversely affecting the functioning of the Company, the same was not required to be read. Also, the Notice convening the Meeting was taken as read. The Managing Director thereafter delivered his speech to the shareholders. The Chairman then informed the Shareholders that the Company had provided the facility of remote e-voting to the Shareholders entitled to vote on all the Resolutions set out in the Notice convening the AGM. He further informed the Shareholders that the facility for e-voting would also be available during the AGM to enable those Shareholders who had not cast their votes through remote e-voting to cast their votes electronically. He further apprised the Shareholders that a period of 15 minutes would be provided for e-voting after the conclusion of the Meeting. The following resolutions as set out in the Notice convening the AGM were put to vote by Remote e-Voting and e-Voting at the Meeting: Ordinary Business 1. To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and the Auditors thereon – (Ordinary Resolution) 2. To appoint a Director in place of Mr. Chetan Shantilal Lalseta, (DIN: 02547012), who retires by rotation at this Annual General Meeting in terms of Section 152(6) of the Companies Act, 2013 and, being eligible, offers himself for re-appointment – (Ordinary Resolution) Special Business 3. Approval of Preferential Allotment of Equity shares – (Special Resolution) Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM APTUS PHARMA LIMITED The Company Secretary and/or the Managing Director was authorised to accept, acknowledge and countersign the Report of the Scrutinizer and to declare the consolidated voting results upon receipt of the Scrutinizer’s Report. The Chairman further informed that [Showing first 8,000 characters — download PDF for full document]